专利详细信息
专利号 | US20120294800A1 |
专利标题 | Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
专利权人 | Rutgers, The State University Of New Jersey; |
发明人 | Lin, Siang-yo;Bertino, Joseph R.;Lin, Chen-yong; |
申请号 | US13/510801 |
申请日 | 2010/11/18 |
公开日 | 2012/11/22 |
优先权号 | |
IPC | A61K03939500; |
专利类型 | |
法律状态查询 | 查看法律状态 |
The present invention relates to matriptase antibodies and immunoconjugates of matriptase antibodies with cytotoxic agents and the use thereof for killing or inhibiting the growth of matriptase-expressing cancer cells such as those of multiple myeloma and breast cancers. In particular immunoconjugates comprising a matriptase monoclonal antibody and anticancer agents such as doxorubicin (DOX) are introduced which are equipotent to anticancer agents used in free form but exhibit significantly reduced cardiotoxicity and almost no adverse effects on normal bone marrow-derived mesenchymal stromal cells that do not express matriptase. The present invention also provides compositions comprising these new immunoconjugates and use of them for treatment of malignancies comprising cells that express matriptase. In addition administration of a matriptase antibody or immunoconjugates of a matriptase antibody and a cytotoxic agent in combination with administration of an immunomodulatory agent such as thalidomide or an analog thereof provides a more effective treatment of these cancers.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。